Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BQ-123 for Microvascular Dysfunction in NSTEMI
NCT00586820Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- May 2005
- Primary completion
- Jan 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in non-ST-elevation myocardial infarction (NSTEMI) comparing BQ-123 with Placebo (2 arms). Primary endpoint: Average Peak Velocity. Started May 2005; status: completed.
02
Drugs
BQ-123
03
Conditions
non-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT00586820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00586820.